-+ 0.00%
-+ 0.00%
-+ 0.00%
Coeptis Therapeutics Announces Nasdaq Grants Approval For Post-Merger Listing Under 'ZSQR' Ticker; Coeptis-Z Squared Merger Expected To Close Q2 2026
Share
Listen to the news

The transaction remains subject to satisfaction of any remaining customary closing conditions, and there can be no assurance that such conditions will be satisfied.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending